Richard Pazdur | |
|---|---|
| Director of the Oncology Center of Excellence | |
| Assumed office 2005 | |
| Personal details | |
| Education | Northwestern University, Stritch School of Medicine |
| Scientific career | |
| Fields | Oncology |
| Institutions | Food and Drug Administration |
Richard Pazdur is an American oncologist serving as the founding director of the Oncology Center of Excellence within the Food and Drug Administration. He was appointed to the position in 2005. He was previously the director of the FDA's Office of Hematology Oncology Products from 1999 to 2005.[1]
YouTube Encyclopedic
-
1/1Views:534
-
Dr. Richard Pazdur on the Breakthrough Designation Requirements
Transcription
Career
Richard earned a Bachelor of Science degree from Northwestern University in 1973, followed by a Doctor of Medicine from Loyola University Stritch School of Medicine. He then did his fellowship at Rush-Presbyterian-St. Luke's Medical Center. He was on the faculty of Wayne State University from 1982 to 1988. He would then join MD Anderson Cancer Center from 1988 to 1999.[2][1]
Pazdur is best known for growing the FDA oncology center from a small generalized division to over hundreds of oncologists across a number of specialties. He was credited with achieving faster approval times for cancer drugs. The office was formed as the Office of Hematology and Oncology Products (OHOP) in 2005 before being launched as the Oncology Center of Excellence in 2017 as part of the Cancer Moonshot Initiative.[3]
Personal life
Pazdur grew up in Calumet City, Illinois.[4] Pazdur met his wife Mary, an oncology nurse practitioner, while training at Rush-Presbyterian-St. Luke's Medical Center. They were married in Chicago prior to starting his new position at Wayne State.[1]
References
- ^ a b c Printz, Carrie (June 2021). "First person profile: Richard Pazdur, MD: The founding director of the FDA's Oncology Center of Excellence has long spearheaded major initiatives to improve oncology drug development". Cancer. 127 (11): 1731–1733. doi:10.1002/cncr.33631. PMID 33970487. S2CID 234346640.
- ^ Commissioner, Office of the (23 April 2019). "Richard Pazdur". U.S. Food and Drug Administration.
- ^ "FDA officially launches its Oncology Center of Excellence (OCE)". WEP Clinical. 31 January 2017. Retrieved 23 May 2022.
- ^ Hagen, Tony (30 December 2019). "Pazdur Followed the Pathway of Greatest Resistance to the FDA". OncologyLive.
| Authority control databases: Academics |
|---|
This page was last edited on 13 August 2023, at 11:01